Cargando…
Feasibility and Efficacy of Intra‐Arterial Administration of Mesenchymal Stem Cells in an Animal Model of Double Toxin‐Induced Multiple System Atrophy
Multiple system atrophy (MSA) is a sporadic neurodegenerative disease of the central and autonomic nervous system. Because no drug treatment consistently benefits MSA patients, neuroprotective strategy using mesenchymal stem cells (MSCs) has a lot of concern for the management of MSA. In this study,...
Autores principales: | Na Kim, Ha, Yeol Kim, Dong, Hee Oh, Se, Sook Kim, Hyung, Suk Kim, Kyung, Hyu Lee, Phil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442709/ https://www.ncbi.nlm.nih.gov/pubmed/28296268 http://dx.doi.org/10.1002/sctm.16-0438 |
Ejemplares similares
-
The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase‐2 on Extracellular α‐Synuclein Aggregates in Parkinsonian Models
por: Oh, Se Hee, et al.
Publicado: (2016) -
Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy
por: Chung, Seok Jong, et al.
Publicado: (2021) -
Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models
por: Kim, Ha Na, et al.
Publicado: (2021) -
Mesenchymal stem cells stabilize the blood–brain barrier through regulation of astrocytes
por: Park, Hyun Jung, et al.
Publicado: (2015) -
Atrophy of Optic Nerve in Erysipelas of the Face
por: Parinaud,, et al.
Publicado: (1879)